Rediff-TV 📺

This browser does not support the video element.

Disclaimer: This image is entirely AI-generated and is a product of artificial intelligence. Any resemblance to actual persons, whether living or deceased, is purely coincidental and unintentional.

11 hours ago

Duration: 0h 3m 31s

Pharma cos may see short-term price blip: Ind-Ra

Name: Pharma cos may see short-term price blip: Ind-Ra
Uploaded: Wed, 27 Aug 2025 11:28:12 +0530
Channel: Rediff Video Desk
Description: Any potential tariffs on pharmaceutical imports into the US are unlikely to impact the credit profiles of Indian firms except for a short-term pricing blip, according to a report by India Ratings and Research (Ind-Ra).The report stated that the US generics market contributes around 35 per cent to the total revenue of the leading Indian pharma firms.

Any potential tariffs on pharmaceutical imports into the US are unlikely to impact the credit profiles of Indian firms except for a short-term pricing blip, according to a report by India Ratings and Research (Ind-Ra). The report stated that the US generics market contributes around 35 per cent to the total revenue of the leading Indian pharma firms.

Uploaded by: Rediff Video Desk on Wed, 27 Aug 2025 11:28:12 +0530

Views: 89

Tags: Pharma cos may see short-term price blip: Ind-Ra